Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist Watchlist | Portfolio Portfolio | Dashboard Dashboard
Hi,
Site News
Contact
Market:
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.
Menu

Sight Sciences Inc (SGHT)

Sight Sciences Inc (SGHT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch Watch
Help
Go To:
TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease GlobeNewswire - Wed Aug 19, 6:05AM CDT

MENLO PARK, Calif., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative interventional technologies...

SGHT : 8.55 (+1.66%)
TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease GlobeNewswire - Wed Aug 19, 6:05AM CDT

MENLO PARK, Calif., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative interventional technologies...

SGHT : 8.55 (+1.66%)
Sight Sciences Reports Second Quarter 2026 Financial Results GlobeNewswire - Wed Aug 5, 3:05PM CDT

Raises Full-Year 2026 Revenue Guidance and Reduces Adjusted Operating Expense Guidance

SGHT : 8.55 (+1.66%)
Sight Sciences Announces Aetna Coverage for OMNI and SION Surgical Systems GlobeNewswire - Wed Aug 5, 3:04PM CDT

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,...

SGHT : 8.55 (+1.66%)
Sight Sciences Announces Aetna Coverage for OMNI and SION Surgical Systems GlobeNewswire - Wed Aug 5, 3:04PM CDT

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,...

SGHT : 8.55 (+1.66%)
Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System GlobeNewswire - Tue Aug 4, 4:37PM CDT

MENLO PARK, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative interventional technologies...

SGHT : 8.55 (+1.66%)
Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System GlobeNewswire - Tue Aug 4, 4:37PM CDT

New system expands the Company’s leadership in interventional glaucoma with the first FDA cleared MIGS device for single pass canaloplasty with TruSync™...

SGHT : 8.55 (+1.66%)
Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewswire - Wed Jul 22, 3:05PM CDT

MENLO PARK, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,...

SGHT : 8.55 (+1.66%)
Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewswire - Wed Jul 22, 3:05PM CDT

MENLO PARK, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company...

SGHT : 8.55 (+1.66%)
Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance GlobeNewswire - Wed May 6, 3:05PM CDT

MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (

SGHT : 8.55 (+1.66%)

Barchart Exclusives

How to Play the Post-Earnings Selloff in Marvell Technology Stock Barchart - Fri Aug 28, 3:13PM CDT
Marvell shares sink despite a strong Q2 print and future guidance. BofA and options data suggest buying the dip in MRVL stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.